Mostrar el registro sencillo del ítem

dc.contributor.authorJiménez Sousa, María Ángeles
dc.contributor.authorMedrano, Luz María
dc.contributor.authorLiu, Pilar
dc.contributor.authorFernández Rodríguez, Amanda
dc.contributor.authorAlmansa Mora, Raquel 
dc.contributor.authorGómez Sánchez, Esther 
dc.contributor.authorOrtega, Alicia
dc.contributor.authorHeredia Rodríguez, María 
dc.contributor.authorGómez Pesquera, Estefanía 
dc.contributor.authorTamayo Gómez, Eduardo 
dc.contributor.authorResino, Salvador
dc.date.accessioned2021-03-05T11:35:36Z
dc.date.available2021-03-05T11:35:36Z
dc.date.issued2017
dc.identifier.citationAnnals of Intensive Care, 2017, vol. 7. 9 p.es
dc.identifier.issn2110-5820es
dc.identifier.urihttp://uvadoc.uva.es/handle/10324/45488
dc.descriptionProducción Científicaes
dc.description.abstractBackground: Sepsis is a life-threatening organ dysfunction caused by a dysregulated host response to infection, being the primary cause of death from infection, especially if not recognized and treated promptly. The aim of this study was to analyze whether IL-6 rs1800795 polymorphism is associated with septic shock-related death in European white patients who underwent major surgery. Methods: We performed a retrospective study on 202 septic shock patients who underwent major cardiac or abdominal surgery. The septic shock was established according to the international septic shock definition. The primary outcome variable was the death within 90 days after diagnosis of septic shock. The IL-6 rs1800795 polymorphism was genotyped by Sequenom’s MassARRAY platform. Results: The median age of the patients was 73 years, 63.4% were male, and more than 40% of patients had heart disease and hypertension. Overall, the survival analysis showed that 111 (55%) patients died with a survival median of 39 days (95% CI 30.7; 47.2). The genetic analysis association with survival was performed under a recessive genetic model (CC vs. GG/CG). Patients with IL-6 rs1800795 CC genotype had higher mortality rate than the IL-6 rs1800795 GG/CG genotype at days 7 [31.6% (6/19) vs. 10.4% (19/183); log-rank test (p = 0.005)] and 28 [57.9% (11/19) vs. 33.3% (61/183); log-rank test (p = 0.009)], and 90 [68.4% (13/19) vs. 53.5% (98/183); log-rank test (p = 0.006)]. The IL-6 rs1800795 CC genotype was associated with higher risk of septic shock-related death during the first 7 days [adjusted hazard ratio (aHR 4.65; p = 0.002), 28 days (aHR 2.50; p = 0.006), and 90 days (aHR 2.28; p = 0.006)] with septic shock. When patients were stratified by type of surgery, those with IL-6 rs1800795 CC genotype who underwent cardiac surgery had higher risk of death during the first 7 days (aHR 18.39; p = 0.001) and 28 days (aHR 6.1; p = 0.025) than IL-6 rs1800795 GG/GC carrier, whereas patients with IL-6 rs1800795 CC genotype who underwent abdominal surgery had higher risk of death during all follow-up (aHR 1.98; p = 0.050) than IL-6 rs1800795 GG/GC carrier. Conclusions: The presence of IL-6 rs1800795 CC genotype was associated with higher risk of septic shock-related death in patients who underwent major cardiac or abdominal surgery. These findings need robust validation in bigger independent cohorts.es
dc.format.mimetypeapplication/pdfes
dc.language.isoenges
dc.publisherSpringeres
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.classificationInterleukin-6es
dc.subject.classificationInterleucina-6es
dc.subject.classificationSingle nucleotide polymorphismes
dc.subject.classificationPolimorfismo de nucleótido únicoes
dc.subject.classificationSeptic shockes
dc.subject.classificationChoque sépticoes
dc.subject.classificationMajor surgeryes
dc.subject.classificationCirugía mayores
dc.titleIL-6 rs1800795 polymorphism is associated with septic shock-related death in patients who underwent major surgery: a preliminary retrospective studyes
dc.typeinfo:eu-repo/semantics/articlees
dc.rights.holder© 2017 Springeres
dc.identifier.doi10.1186/s13613-017-0247-8es
dc.relation.publisherversionhttps://annalsofintensivecare.springeropen.com/articles/10.1186/s13613-017-0247-8es
dc.peerreviewedSIes
dc.description.projectInstituto de Salud Carlos III (grants PI15/01451, CD13/00013, CD14/00002, and CP14CIII/00010)es
dc.description.projectJunta de Castilla y Leon (grants 463/A/10 and 773/A/13)es
dc.description.projectPFIZER (grant CT25-ESP01-01)es
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem